Latest News and Press Releases

Lungpacer Medical today announced the first six patients enrolled in the groundbreaking STARI clinical trial.

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Neurology Devices Market Size, Share, Growth, Trends, Opportunity, and Forecast, 2025-2033" report has been added to ...

Access to Apollo TMS Therapy has expanded in the United States, extending coverage to Adolescents suffering from Major Depression.

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The CE Mark certification allows marketing for both clinic and...

The Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-on Payment (NTAP) status for Lungpacer's AeroPace® System.

PathMaker Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Denison is Professor of Clinical Neurosciences at the University...

FDA 510(k) application submitted to allow marketing of the ARC-EX® System for home use in the United StatesCE Mark application filed with notified body to enable commercialization of the ARC-EX System...

EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement,...

Dallas, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal clinical trial, which aims to improve...